Smaller practices should participate in clinical research. Here’s how they can.
The COVID-19 pandemic and the resulting shutdown accelerated the adoption of decentralized clinical trials (DCTs). The number of trials with virtual and/or decentralized elements exceeded 1,000 in 2021 for the first time, according to GlobalData. That’s a 50 percent increase from 2020. GlobalData expects the number of site-less and/or virtual clinical trials to jump another 28 percent this year, potentially topping 1,400.
This presents a perfect opportunity for smaller and …
